Lv3
290 积分 2022-08-28 加入
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
1天前
待确认
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial
1天前
已完结
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial
2天前
已完结
SBRT feasible for oligometastatic RCC
2天前
已完结
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium
6天前
已完结
LDHA‐mediated M2‐type macrophage polarization via tumor‐derived exosomal EPHA2 promotes renal cell carcinoma progression
7个月前
已完结
肾动脉分支阻断与主干阻断在机器人辅助腹腔镜肾部分切除术治疗早期肾癌中的疗效对比
1年前
已完结
肾动脉分支阻断与主干阻断在机器人辅助腹腔镜肾部分切除术治疗早期肾癌中的疗效对比
1年前
已关闭
超选择性肾动脉分支阻断技术在经腹腹腔镜肾部分切除术中的初步应用
1年前
已关闭
机器人腹腔镜零缺血与肾动脉主干阻断肾部分切除术治疗T_(1a)期外生性肾脏肿瘤的临床研究
1年前
已完结
皖公网安备34019202002308
